- Home
- QNST vs ARDX Comparison
QNST vs ARDX Comparison
Compare QNST & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNST
- ARDX
- Stock Information
- Founded
- QNST 1999
- ARDX 2007
- Country
- QNST United States
- ARDX United States
- Employees
- QNST N/A
- ARDX N/A
- Industry
- QNST Business Services
- ARDX Biotechnology: Pharmaceutical Preparations
- Sector
- QNST Consumer Discretionary
- ARDX Health Care
- Exchange
- QNST Nasdaq
- ARDX Nasdaq
- Market Cap
- QNST 923.2M
- ARDX 882.9M
- IPO Year
- QNST 2010
- ARDX 2014
- Fundamental
- Price
- QNST $15.68
- ARDX $6.36
- Analyst Decision
- QNST Buy
- ARDX Strong Buy
- Analyst Count
- QNST 6
- ARDX 9
- Target Price
- QNST $27.33
- ARDX $10.50
- AVG Volume (30 Days)
- QNST 582.4K
- ARDX 4.5M
- Earning Date
- QNST 08-07-2025
- ARDX 08-04-2025
- Dividend Yield
- QNST N/A
- ARDX N/A
- EPS Growth
- QNST N/A
- ARDX N/A
- EPS
- QNST 0.08
- ARDX N/A
- Revenue
- QNST $1,093,711,000.00
- ARDX $386,146,000.00
- Revenue This Year
- QNST $10.36
- ARDX $16.83
- Revenue Next Year
- QNST $9.78
- ARDX $28.55
- P/E Ratio
- QNST $196.50
- ARDX N/A
- Revenue Growth
- QNST 78.27
- ARDX 83.88
- 52 Week Low
- QNST $14.27
- ARDX $3.21
- 52 Week High
- QNST $26.27
- ARDX $7.18
- Technical
- Relative Strength Index (RSI)
- QNST 51.99
- ARDX 80.08
- Support Level
- QNST $15.39
- ARDX $6.00
- Resistance Level
- QNST $15.89
- ARDX $6.43
- Average True Range (ATR)
- QNST 0.42
- ARDX 0.22
- MACD
- QNST 0.08
- ARDX 0.02
- Stochastic Oscillator
- QNST 84.56
- ARDX 93.37
About QNST QuinStreet Inc.
QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia.
About ARDX Ardelyx Inc.
Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.